ZVRA logo

Zevra Therapeutics (ZVRA) Non Current Assets

Annual Non Current Assets

$85.39 M
+$62.88 M+279.41%

31 December 2023

ZVRA Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$92.11 M
+$8.59 M+10.29%

30 September 2024

ZVRA Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ZVRA Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+279.4%+4578.0%
3 y3 years+2920.5%+3503.6%
5 y5 years+2722.8%+2089.9%

ZVRA Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+2920.5%at high+4578.0%
5 y5 yearsat high+2920.5%at high+4578.0%
alltimeall timeat high>+9999.0%at high>+9999.0%

Zevra Therapeutics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$92.11 M(+10.3%)
June 2024
-
$83.52 M(-5.5%)
Mar 2024
-
$88.39 M(+3.5%)
Dec 2023
$86.94 M(-6.4%)
$85.39 M(+4236.7%)
Sept 2023
-
$1.97 M(-5.8%)
June 2023
-
$2.09 M(-9.7%)
Mar 2023
-
$2.31 M(-89.7%)
Dec 2022
$92.83 M(-19.3%)
$22.51 M(-34.6%)
Sept 2022
-
$34.42 M(-6.5%)
June 2022
-
$36.82 M(+84.8%)
Mar 2022
-
$19.93 M(+11.4%)
Dec 2021
$115.06 M(+1272.7%)
-
Dec 2021
-
$17.89 M(+599.7%)
Sept 2021
-
$2.56 M(-2.3%)
June 2021
-
$2.62 M(-3.3%)
Mar 2021
-
$2.71 M(-4.3%)
Dec 2020
$8.38 M(+20.2%)
$2.83 M(-7.6%)
Sept 2020
-
$3.06 M(-6.2%)
June 2020
-
$3.26 M(-3.3%)
Mar 2020
-
$3.37 M(-4.6%)
Dec 2019
$6.97 M
$3.54 M(-16.0%)
DateAnnualQuarterly
Sept 2019
-
$4.21 M(-3.7%)
June 2019
-
$4.37 M(-4.1%)
Mar 2019
-
$4.56 M(+50.6%)
Dec 2018
$23.72 M(-48.3%)
$3.02 M(+51.2%)
Sept 2018
-
$2.00 M(-35.3%)
June 2018
-
$3.09 M(-13.4%)
Mar 2018
-
$3.57 M(-45.6%)
Dec 2017
$45.90 M(-38.3%)
$6.56 M(-28.0%)
Sept 2017
-
$9.12 M(-33.4%)
June 2017
-
$13.68 M(+8.4%)
Mar 2017
-
$12.62 M(+19.9%)
Dec 2016
$74.36 M(+37.5%)
$10.53 M(-64.0%)
Sept 2016
-
$29.28 M(+45.9%)
June 2016
-
$20.07 M(+3535.1%)
Mar 2016
-
$552.00 K(+7.8%)
Dec 2015
$54.08 M(+426.2%)
$512.00 K(-71.6%)
Sept 2015
-
$1.80 M(+5.3%)
June 2015
-
$1.71 M(-55.0%)
Mar 2015
-
$3.80 M(+10.5%)
Dec 2014
$10.28 M(+403.9%)
$3.44 M
Dec 2013
$2.04 M
-

FAQ

  • What is Zevra Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Zevra Therapeutics?
  • What is Zevra Therapeutics annual non current assets year-on-year change?
  • What is Zevra Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Zevra Therapeutics?
  • What is Zevra Therapeutics quarterly non current assets year-on-year change?

What is Zevra Therapeutics annual long term assets?

The current annual non current assets of ZVRA is $85.39 M

What is the all time high annual non current assets for Zevra Therapeutics?

Zevra Therapeutics all-time high annual long term assets is $85.39 M

What is Zevra Therapeutics annual non current assets year-on-year change?

Over the past year, ZVRA annual long term assets has changed by +$62.88 M (+279.41%)

What is Zevra Therapeutics quarterly long term assets?

The current quarterly non current assets of ZVRA is $92.11 M

What is the all time high quarterly non current assets for Zevra Therapeutics?

Zevra Therapeutics all-time high quarterly long term assets is $92.11 M

What is Zevra Therapeutics quarterly non current assets year-on-year change?

Over the past year, ZVRA quarterly long term assets has changed by +$90.14 M (+4577.96%)